- HOME >
- News
News
Royal Society of New Zealand honours GM of GlycoSyn
December 2006GlycoSyn's General Manager, Dr Richard Furneaux, has been awarded the Hector Medal from the Royal Society of New Zealand.
Industrial Research and Institute of Molecular and Cell Biology to collaborate on stem cell research
September 2006The work will ultimately target new therapeutics for bone healing and is seen as the beginnings of a broader research and development partnership with Singapore.
GlycoSyn works on Parkinson’s Drug
August 2006GlycoSyn has nearly completed the manufacture of the key ingredient for a new drug designed to slow the progression of Parkinson’s Disease.
A winning year for IRL and Australasia’s biotechnology industry
July 2006Industrial Research Limited’s (IRL) Carbohydrate Chemistry platform has delivered the Australasian Biotech industry’s biggest year on record - since the industry was founded in Australia and New Zealand in the mid 1980’s.
Industrial Research Limited lands significant pharmaceutical production deal
July 2006The active ingredient for a new drug designed to prevent genital herpes and HIV-AIDS will be manufactured in New Zealand with the signing of a major contract.
Starpharma and Industrial Research Ltd Establish Joint Venture to
Commercialise Glycodendrimers as Pharmaceuticals - Joint Venture Supported by $NZ945,000 Grant
Melbourne, Australia, 3 March 2005
Starpharma Holdings Limited (ASX: SPL, USOTC:SPHRY) of Melbourne, Australia and Industrial Research Limited, New Zealand, today announced that they have entered into a joint venture to accelerate the development of carbohydrate functionalised dendrimers (glycodendrimers) for use in therapeutics, antigen presentation and as biologically active compounds.
Forerunner of New Pharmaceutical Industry in New Zealand
March 2003New Zealand's potential as a high-value manufacturer of next generation drugs that target cancer and other diseases was signalled with the opening of a $7 million facility in Lower Hutt today (26 March 2003)
New era for New Zealand organic chemistry synthesis capability
November 2002New Zealand's ability to take newly discovered pharmaceutical candidates all the way from the laboratory to human clinical trials will receive a boost with the opening in March 2003 of a new $6 million glycotherapeutics synthesis development and production facility.